At close: December 27 at 6:16:04 PM GMT+1
Loading Chart for R9U2.MU
DELL
- Previous Close
7.53 - Open
7.61 - Bid 7.39 x --
- Ask 7.54 x --
- Day's Range
7.36 - 7.61 - 52 Week Range
7.36 - 14.28 - Volume
1,000 - Avg. Volume
412 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Feb 26, 2025 - Mar 3, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: R9U2.MU
View MorePerformance Overview: R9U2.MU
Trailing total returns as of 12/27/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
R9U2.MU
27.89%
S&P/TSX Composite index
18.31%
1-Year Return
R9U2.MU
18.14%
S&P/TSX Composite index
18.75%
3-Year Return
R9U2.MU
56.84%
S&P/TSX Composite index
16.80%
5-Year Return
R9U2.MU
1.10%
S&P/TSX Composite index
44.33%
Compare To: R9U2.MU
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
7.36
-2.39%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
4.5380
-2.91%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
5.05
-10.62%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
4.6100
-2.16%
Mkt Cap EUR 873.152M
Industry Drug Manufacturers—Specialty & Generic
4.4600
-1.28%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
5.90
+6.31%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
5.45
-4.39%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
4.5690
-1.40%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
5.05
-9.82%
Mkt Cap EUR 418.433M
Industry Drug Manufacturers—Specialty & Generic
1.3560
+7.19%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
4.5720
-1.34%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
Statistics: R9U2.MU
View MoreValuation Measures
As of 12/27/2024
Market Cap
1.76B
Enterprise Value
2.10B
Trailing P/E
28.39
Forward P/E
31.25
PEG Ratio (5yr expected)
0.53
Price/Sales (ttm)
1.64
Price/Book (mrq)
1.02
Enterprise Value/Revenue
1.96
Enterprise Value/EBITDA
5.83
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--